<VariationArchive VariationID="810636" VariationName="NM_004562.3(PRKN):c.101del (p.Gln34fs)" VariationType="Deletion" Accession="VCV000810636" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2020-04-06" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="798915" VariationID="810636">
      <GeneList>
        <Gene Symbol="PRKN" FullName="parkin RBR E3 ubiquitin protein ligase" GeneID="5071" HGNC_ID="HGNC:8607" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q26</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="161347417" stop="162727766" display_start="161347417" display_stop="162727766" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="161768589" stop="163148833" display_start="161768589" display_stop="163148833" Strand="-" />
          </Location>
          <OMIM>602544</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004562.3(PRKN):c.101del (p.Gln34fs)</Name>
      <CanonicalSPDI>NC_000006.12:162443379:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q26</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="162443380" stop="162443380" display_start="162443380" display_stop="162443380" variantLength="1" positionVCF="162443379" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="162864412" stop="162864412" display_start="162864412" display_stop="162864412" variantLength="1" positionVCF="162864411" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Q34fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.162864412del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.162864412del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.162443380del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.162443380del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008289.2" sequenceAccession="NG_008289" sequenceVersion="2" change="g.289423del">
            <Expression>NG_008289.2:g.289423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.3" sequenceAccession="NM_004562" sequenceVersion="3" change="c.101del" MANESelect="true">
            <Expression>NM_004562.3:c.101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004553.2" sequenceAccession="NP_004553" sequenceVersion="2" change="p.Gln34fs">
            <Expression>NP_004553.2:p.Gln34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013987.3" sequenceAccession="NM_013987" sequenceVersion="3" change="c.101del">
            <Expression>NM_013987.3:c.101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054642.2" sequenceAccession="NP_054642" sequenceVersion="2" change="p.Gln34fs">
            <Expression>NP_054642.2:p.Gln34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013988.3" sequenceAccession="NM_013988" sequenceVersion="3" change="c.101del">
            <Expression>NM_013988.3:c.101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054643.2" sequenceAccession="NP_054643" sequenceVersion="2" change="p.Gln34fs">
            <Expression>NP_054643.2:p.Gln34fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.3" sequenceAccession="NM_004562" sequenceVersion="3" change="c.101delA" MANESelect="true">
            <Expression>NM_004562.3:c.101delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602544.0009" DB="OMIM" />
        <XRef Type="rs" ID="748142049" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004562.3(PRKN):c.101del (p.Gln34fs) AND Autosomal recessive juvenile Parkinson disease 2" Accession="RCV001030787" Version="5">
        <ClassifiedConditionList TraitSetID="1942">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-08-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-08-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-06" MostRecentSubmission="2022-12-31">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11402119</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12707457</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32214227</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2274468" SubmissionDate="2019-11-26" DateLastUpdated="2020-04-06" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="NM_004562.3:c.101delA|OMIM: 600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001156100" DateUpdated="2020-04-06" DateCreated="2020-04-06" Type="SCV" Version="1" SubmitterName="Section for Clinical Neurogenetics, University of TÃ¼bingen" OrgID="507314" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">32214227</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11402119</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.3:c.101delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">32214227</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32214227</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>TLP001</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27660" SubmissionDate="2013-12-19" DateLastUpdated="2022-12-31" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602544.0009_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" title="PRKN, 1-BP DEL, 202A_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" />
        <ClinVarAccession Accession="SCV000027660" DateUpdated="2022-12-31" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-04-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected brothers from a sibship of 10 in an Arabic Muslim Israeli family segregating Parkinson disease (600116), Nisipeanu et al. (2001) found homozygosity for deletion of 1 adenine at nucleotide 202 in exon 2 of the PARK2 gene. The mutation led to a frameshift and premature termination 8 amino acid residues downstream. Ages at onset were 35, 33, 37, and 30 years, and the disease duration 27, 22, 9, and 14 years. The parkinsonian symptomatology was similar in all. Hand tremor was the first symptom; later, bradykinesia and rigidity were observed. In addition to the rest tremor, all presented postural hand tremor. None had orthostatic hypotension, urinary dysfunction, constipation, sleep benefit, or diurnal variation. Response to levodopa therapy was excellent and the total daily dose remained low for a long period.</Attribute>
              <Citation>
                <ID Source="PubMed">11402119</ID>
              </Citation>
              <XRef DB="OMIM" ID="600116" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Inzelberg et al. (2003) identified another branch of the family reported by Nisipeanu et al. (2001) in which 2 first cousins carried the same homozygous 202delA mutation in the PARK2 gene. Both patients had early-onset parkinsonism (onset at ages 19 and 23), with the additional feature of truncal dystonia. One developed camptocormia with severe trunk flexion (up to 90 degrees), and the other had axial dystonia and scoliosis. The authors noted the phenotypic heterogeneity of the mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">12707457</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11402119</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <Name>PRKN, 1-BP DEL, 202A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 202A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602544.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27660" TraitType="Disease" MappingType="Name" MappingValue="PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2274468" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

